Prof Paul Townsend
Non-Executive Director & Scientific Advisory Board
Paul is a HEFCE funded group leader and Full Professor in Division of Cancer Sciences at the University of Manchester. He is also Associate Dean of Business Engagement and Innovation in the Faculty of Biology, Medicine and Health. He also leads Industry and Innovation for the Manchester BRC and is Industry lead for the Manchester Academic Health Sciences Centre. Previously Paul held the position of Chair of Molecular Cell Biology at the University of Southampton, where he was also Associate Director of Enterprise & Innovation for the Faculty of Medicine and Deputy Director of Cancer Sciences within the Cancer Research UK Clinical Centre and Lymphoma and Leukaemia Research Centre of Excellence. Paul has spent time on the board of several start-up companies and held a position of Business Fellow with the London Technology Network. Paul co-founded Karus Therapeutics in July 2005, a biotechnology spinout company. Karus recently relocated to Harwell Science Park, Oxford following significant Series B fund raising. Paul relocated to Manchester 2013 and is highly active in research, generating >£3.5million in research income and maintaining a strong track record of recent publications. The reputation of Paul’s research is reflected in continued invitations to present in the UK and international conferences.